← Insider Monitor
4D Molecular Therapeutics, Inc. logo
FDMT

4D Molecular Therapeutics, Inc.

Nasdaq · Biological Products, (No Diagnostic Substances)

3
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

4D Molecular Therapeutics is a clinical-stage gene therapy company that engineers adeno-associated virus (AAV) vectors to develop treatments for ophthalmology, cardiology, and pulmonology diseases, including wet age-related macular degeneration and cystic fibrosis.

Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Emeryville, CA
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
Kirn DavidSee RemarksSell$750KOct 5, 2026
Kirn DavidSee RemarksSell$4KOct 5, 2026
Bizily ScottChief Legal OfficerSell$22KSep 16, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for FDMT.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable FDMT activity by email

Free alerts for the insider and congressional trades worth watching.

SMS is optional: we only save your number if you check the consent box and provide a valid number. US mobile numbers only.

SMS Terms and Privacy Policy.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.